Eli Lilly expects US FDA approval for oral obesity drug in March 2026
Lilly(US:LLY) Reutersยท2025-11-06 21:48Eli Lilly expects the U.S. Food and Drug Administration to approve its experimental oral obesity drug, orforglipron, by March 2026, its chief executive said on Thursday. ...